Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Artivion (NYSE: AORT), a cardiac and vascular surgery company specializing in aortic disease, has announced its participation in two upcoming investor conferences. The company will present at the Truist Securities MedTech Conference on June 17, 2025, at 8:00 a.m. ET at the InterContinental Boston Hotel, with a live webcast available on their website www.artivion.com. The webcast recording will be accessible for 90 days afterward. Additionally, Artivion's management team will participate in investor meetings at the Citizens Medical Devices and Healthcare Services Forum on the same day, though no webcast will be available for this event due to its format.

News Market Reaction

+0.74%

1 alert

+0.74% News Effect

On the day this news was published, AORT gained 0.74%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ATLANTA, June 3, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investors conferences.

Artivion's management team will present at the upcoming Truist Securities MedTech Conference on Tuesday, June 17, 2025, at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 8:00 a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website. 

Artivion management will also be participating in investor meetings at the Citizens Medical Devices and Healthcare Services Forum on Tuesday, June 17, 2025. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

Artivion	Gilmartin Group LLC
Lance A. Berry	Brian Johnston / Laine Morgan
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302472312.html

SOURCE Artivion, Inc.

FAQ

When is Artivion (AORT) presenting at the Truist Securities MedTech Conference 2025?

Artivion will present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025, at 8:00 a.m. ET at the InterContinental Boston Hotel.

How can I watch Artivion's (AORT) presentation at the Truist Securities Conference?

The presentation can be watched via live webcast through Artivion's website www.artivion.com on the Investors page, with the recording available for 90 days afterward.

Which investor conferences is Artivion (AORT) attending in June 2025?

Artivion is attending two conferences: the Truist Securities MedTech Conference and the Citizens Medical Devices and Healthcare Services Forum, both on June 17, 2025.

Will there be a webcast for Artivion's participation at the Citizens Medical Devices Forum?

No, there will not be a webcast available for the Citizens Medical Devices and Healthcare Services Forum due to the format of the event.